21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
Forazolines, compositions thereof and uses thereof
#2102Indoline derivatives for treatment and/or prevention of fibrosis diseases
#2103FORMULATIONS CONTAINING OMEGA-3 FATTY ACIDS OR ESTERS THEREOF AND MAQUI BERRY EXTRACT AND THERAPEUTIC USES THEREOF
#2104Methods and compositions for improving microvascular function, suppressing cyclooxygenase activity, reducing platelet aggregation and increasing levels of resveratrol in plasma
#2105Method of treating a dopamine related disorder in a subject by administering levodopa, in combination with a dopamine decarboxylase inhibitor and a catechol-o-methyltransferase inhibitor
#2106METHOD FOR TREATING INTESTINAL FIBROSIS
#2107Compositions and methods for enhancing virus replication
#2108Multipotential Expanded Mesenchymal Precursor Cell Progeny (MEMP) and Uses Thereof
#2109MODIFIED 2' AND 3'-NUCLEOSIDE PRODRUGS FOR TREATING FLAVIVIRIDAE INFECTIONS
#2110Tricyclic fused pyridin-2-one derivatives and their use as BRD4 inhibitors
#2111Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer
#2112Composition and methods of use of novel phenylalanine small organic compounds to directly modulate PCSK9 protein activity
#2113Thymidine kinase gene
#2114ALPHA AND GAMMA-D POLYGLUTAMATED ANTIFOLATES AND USES THEREOF
#2115Method for enhancing specific immunotherapies in cancer treatment
#2116Therapeutic agents for pancreatic cancer
#2117Combination of the application of antibodies for immunostimulation together with glucocorticoids
#2118METHODS OF TREATING CANCER USING PD-L1 AXIS BINDING ANTAGONISTS AND VEGF ANTAGONISTS
#2119PHARMACEUTICAL COMPOSITION FOR TREATING A METABOLIC SYNDROME
#2120COMBINATION COMPOSITION COMPRISING FGF-18 COMPOUND
#2121Isoform Nell-1 peptide
#2122METHODS FOR THE PREVENTION OR TREATMENT OF HEART FAILURE
#2123Antimicrobial and antiviral composition
#2124Herbo-mineral formulation for prevention, treatment and management of diabetes and method of preparation thereof
#2125Compositions and methods for treating graft versus host disease
#2126Prevention and treatment for microbial infections
#2127COMBINATION THERAPY FOR CANCER TREATMENT
#2128Pharmaceutical formulation
#2129Compositions and methods for increasing energy metabolism
#2130CXCR-2 inhibitors for treating crystal arthropathy disorders
#2131Methods of administering elagolix
#2132Compositions and methods for cancer expressing PDE3A or SLFN12
#2133Liquid pharmaceutical composition
#2134Treatment and management of augmentation in restless legs syndrome
#2135Compounds and methods for treating an epileptic disorder
#2136Treatment of Cancer with Enzalutamide and a CYP3A4 Inhibitor
#2137Methods for controlling the spread of dirofilariosis
#2138COMPOSITIONS FOR TOPICAL APPLICATION COMPRISING BENZOYL PEROXIDE AND ADAPALENE
#2139Pharmaceutical composition containing Bay 11-7082, parthenolide or a combination thereof for the treatment of obesity or cardiovascular diseases
#2140Method of treating hyperglycemia
#2141COMPOSITIONS, METHODS AND KITS FOR TREATMENT OF DIABETES AND/OR HYPERLIPIDEMIA
#2142STABLE PHARMACEUTICAL COMPOSITION OF ALOGLIPTIN AND METFORMIN FIXED DOSE COMBINATION
#2143Sigma receptor ligands and methods of modulating cellular protein homeostasis using same
#2144Platelet membrane-coated drug delivery system
#2145Carrier-binding agent compositions and methods of making and using the same
#2146TRANSDERMAL FORMULATIONS FOR DELIVERY OF BERBERINE COMPOUNDS, AND THEIR USE IN THE TREATMENT OF BERBERINE-RESPONSIVE DISEASES AND CONDITIONS
#2147Composition for anticancer adjuvant comprising RIP3 expression promoter as active ingredient, method for screening anticancer adjuvant which promotes RIP3 expression and enhances sensitivity of anticancer agent, and method for monitoring sensitivity of anticancer agent
#2148Deuterated amlexanox
#21495-(N-fused tricyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
#2150Substituted pyridines as inhibitors of human immunodeficiency virus replication
#2151Bicyclic-Fused Heteroaryl Or Aryl Compounds
#2152Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
#2153PHARMACEUTICAL COMPOSITION, SUBSTRATE COMPRISING A PHARMACEUTICAL COMPOSITION, AND USE OF A PHARMACEUTICAL COMPOSITION
#2154Cross-linked star-shaped self-assembled polypeptides and its use as carriers in biomedical applications
#2155FORMULATION FOR TOPICAL WOUND TREATMENT
#2156Combinations and uses thereof
#2157Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy
#2158Biologically relevant orthogonal cytokine/receptor pairs
#2159Interlaced Method for Treating Cancer or a Precancerous Condition
#2160COMPOSITIONS & METHODS FOR LOWERING INTRAOCULAR PRESSURE
#2161Oral Cephalotaxine Dosage Forms
#2162THERAPEUTICAL USES OF ESLICARBAZEPINE
#2163COMBINATION THERAPY OF HBV AND HDV INFECTION
#21645-bromo-2,6-di-(1H-pyrazol-1-yl)pyrimidin-4-amine for use in the treatment of cancer
#2165COMBINATIONS OF A PYRIMIDINE CONTAINING NNRTI WITH RT INHIBITORS
#2166COMBINATION THERAPY FOR CANCER
#2167METHODS OF TREATING CANCER
#2168Synergistic auristatin combinations
#2169Antimicrobial compositions comprising mupirocin and neomycin
#2170Monoacylglycerols for use in conjunction with a lipase inhibitor and/or diets low in fat and/or calories
#2171RECTAL TOPICAL LIPOGEL COMPRISING AN ANESTHETIC AGENT AND A NON-STEROIDAL ANTI-INFLAMMATORY AGENT FOR PAIN RELIEF
#2172SUBSTANCE SELECTED AMONG MIDODRINE, A PHARMACEUTICAL SALT AND AN ACTIVE METABOLITE THEREOF, FOR USE IN THE TREATMENT OF OBSTRUCTIVE CARDIOPATHY
#2173Adjuvant chemotherapy for anaplastic gliomas
#2174Compositions for use in the treatment of diabetes
#2175COMBINATION THERAPIES TARGETING MITOCHONDRIAL BIOGENESIS FOR CANCER THERAPY
#2176Dermal Delivery Device
#2177DERMAL REJUVENATION COMPOSITIONS AND METHODS
#2178METHOD OF TREATING AND PROGNOSING SCOLIOTIC PATIENT SUBGROUPS
#2179Anti-CS1 antibodies and antibody drug conjugates
#2180Method for treating myelofibrosis comprising administering a transforming growth factor beta type II receptor antagonist
#2181Compositions and methods for inhibiting arginase activity
#21825-(n-[6,5]-fused bicyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
#2183DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS
#2184PH-sensitive linkers for delivering a therapeutic agent
#2185Composition for use in treating and preventing inflammation related disorder
#2186Agents for use in the treatment of glioma
#2187TREATMENT OF PATIENTS DIAGNOSED WITH PANCREATIC DUCTAL ADENOCARCINOMA USING USING MONOCLONAL ANTIBODIES AGAINST THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR)
#2188Benzamide and active compound compositions and methods of use
#2189Carbapenemases for use with antibiotics for the protection of the intestinal microbiome
#2190ENZYME REPLACEMENT THERAPY FOR MUCOPOLYSACCHARIDOSIS IIID
#2191BACTERIOPHAGE LYSIN AND ANTIBIOTIC COMBINATIONS AGAINST GRAM POSITIVE BACTERIA
#2192Formulation Comprising A Stabilized Complex Of Corticotropin Releasing Hormone And Alpha-2 Macroglobulin
#2193Applications of mussel adhesive protein product in treatment and prevention of diseases related to melanin
#2194Antimicrobial fusion peptides
#2195MODULATING URACIL-DNA GLYCOSYLASE AND USES THEREOF
#2196Treatments of oxidative stress conditions
#2197ITCH TREATMENT USING A COMBINATION OF NEUROKININ-1, GASTRIN RELEASING PEPTIDE, AND GLUTAMATE RECEPTOR ANTAGONISTS
#2198ANGIOTENSINS IN MUSCULAR DYSTROPHY
#2199METHODS AND COMPOSITIONS RELATING TO MESENCHYMAL STEM CELL EXOSOMES
#2200THERAPEUTIC COMBINATIONS OF ANTIVIRAL AND ANTI-INFLAMMATORY THERAPIES
#2201Non-irritating testosterone emulsions
#2202Inhibition of MK2 in the treatment of cancer
#2203Combined inhibition of the vitamin D receptor and poly(ADP) ribose polymerase (PARP) in the treatment of cancer
#2204Methods for treating cancer using HSP90 inhibitors
#2205TREATMENT FOR THE FETUS WITH CONGENITAL HEART DISEASE
#2206Combination therapy
#2207COMPOSITIONS AND METHODS FOR TREATING FIBROSING DISORDERS AND CANCER
#2208Compounds and their use as BACE inhibitors
#2209Methods and compositions useful for treating diseases involving Bcl-2 family proteins with quinoline derivatives
#2210Pharmaceutical compositions comprising a local anaesthetic such as bupivacaine for local administration to the mouth or throat
#2211Use of gaboxadol in the treatment of tinnitus
#2212Hepatitis C virus inhibitors
#2213COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING OCULAR DISORDERS
#2214Topical compositions comprising fipronil and permethrin and methods of use
#2215PREVENTION OF ROSACEA INFLAMMATION
#2216Treatment and prevention of muscle loss using L-ornithine in combination with at least one of phenylacetate and phenylbutyrate
#2217COMBINATION THERAPY USING ACAMPROSATE AND D-CYCLOSERINE
#2218Materials and methods for controlling infections
#2219TAMPER RESISTANT DOSAGE FORM WITH BIMODAL RELEASE PROFILE MANUFACTURED BY CO-EXTRUSION
#2220ANTIMICROBIALS AND METHODS OF USE THEREOF FOR WOUND HEALING
#2221Therapeutic composition comprising insulin prepared for delivery into an intestinal tract
#2222Heat-stable dry powder pharmaceutical compositions and methods
#2223Tetrahydroquinoline compositions as BET bromodomain inhibitors
#2224Aminothiazole compounds and methods using same
#2225METHODS FOR INHIBITING NATIVE AND PROMISCUOUS UPTAKE OF MONOAMINE NEUROTRANSMITTERS
#2226IMMUNOSTIMULATORY NANOCARRIER
#2227TREATMENT OF CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND IL-6
#2228Hematopoietic stem cells in combinatorial therapy with immune checkpoint inhibitors against cancer
#2229IMMUNOTHERAPY WITH BINDING AGENTS
#2230METHOD OF ENABLING MUSCLE RELAXATION
#2231Microporous zirconium silicate for the treatment of hyperkalemia
#2232METHODS OF TREATING RETROVIRAL INFECTIONS AND RELATED DOSAGE REGIMES
#2233USE OF PHYTIC ACID OR THE SALTS THEREOF, ALONE OR COMBINED WITH B6 VITAMERS, FOR PREVENTING THE FORMATION OF ADVANCED GLYCATION END-PRODUCT
#2234Combination
#2235Method of diagnosing and treating skin necroptosis disease comprising RIP3-MLKL pathway blocker
#2236METHODS FOR ATTENUATING OR PREVENTING MU(μ)-OPIOID RECEPTOR MEDIATED TOLERANCE AND OPIOID-INDUCED HYPERALGESIA
#2237SEMI-SOLID TOPICAL COMPOSITION CONTAINING PIRFENIDONE AND MODIFIED DIALLYL DISULFIDE OXIDE (M-DDO) FOR ELIMINATING OR PREVENTING ACNE
#2238Pharmaceutical composition comprising rapamycin or derivative thereof, and method for producing the same
#2239COMPOSITIONS, METHODS AND KITS FOR REDUCING LIPID LEVELS
#2240Compositions and methods of use of phorbol esters in the treatment of neoplasms
#2241Methods of treating neurodevelopmental diseases and disorders
#2242Use of short chain fatty acids for the treatment and prevention of diseases and disorders
#2243Topical compositions for pain relief, manufacture and use
#2244Topical compositions for pain relief, manufacture and use
#2245METHODS FOR TREATING CANCER
#2246Dimethyl sulfoxide (DMSO) or DMSO and methylsulfonylmethane (MSM) formulations to treat infectious diseases
#2247Skin punch biopsy and wound-debridgement training model
#2248DIAGNOSTIC TOOLS FOR CHARCOT-MARIE-TOOTH DISEASE
#2249Methods for cytotoxic chemotherapy-based predictive assays
#2250BICYCLIC HETEROCYCLIC DERIVATIVES AS MNK1 AND MNK2 MODULATORS AND USES THEREOF
#2251Compounds for use in treating or preventing cancerous diseases
#2252Indenyl compounds, pharmaceutical compositions, and medical uses thereof
#2253IL-26 inhibitors
#2254COMBINATION THERAPY FOR CANCER
#2255PORCINE IMMUNE MODULATION MODEL
#2256Compositions and methods for inhibition of bacterial infections in human endocervix
#2257METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF FRIEDREICH'S ATAXIA
#2258BIFIDOBACTERIA FOR TREATING CARDIAC CONDITIONS
#2259TREATMENT OF PAPULOPUSTULAR ROSACEA WITH IVERMECTIN
#2260METHODS OF TREATING MYELODYSPLASTIC SYNDROMES WITH A COMBINATION THERAPY USING LENALIDOMIDE AND AZACITIDINE
#2261TREATMENT OF TRIPLE NEGATIVE BREAST CANCER UTILIZING ANDROST-5-ENE-3b,17b-DIOL (b-AED), ANDROST-5-ENE-3b,7b,17b-TRIOL (b-AET) AND ESTRADIOL (E2)
#2262ADMINISTRATION OF AURORA KINASE INHIBITOR AND CHEMOTHERAPEUTIC AGENTS
#2263Compounds and compositions for ossification and methods related thereto
#2264METHODS AND COMPOSITIONS FOR STIMULATING BENEFICIAL BACTERIA IN THE GASTROINTESTINAL TRACT
#2265Bupropion as a modulator of drug activity
#2266THERAPEUTIC COMBINATIONS OF ORALLY ADMINISTERED PACLITAXEL AND A P-gp INHIBITOR FOR THE TREATMENT OF CANCER
#2267ESTROGEN RELATED RECEPTOR GAMMA (ERRgamma) ENHANCES AND MAINTAINS BROWN FAT THERMOGENIC CAPACITY
#2268METHOD OF MAKING CANNABIS OIL HYDROPHILIC USING EMULSIFIERS AND RELATED CANNABINOID COMPOSITIONS
#2269Botanical Antimicrobial Compositions
#2270Boron-containing diacylhydrazine compounds
#2271Compositions comprising oxo-derivatives of fatty acids and methods of making and using same
#2272Pharmaceutical Composition Comprising a GLP-1 Agonist, an Insulin and Methionine
#2273Vitamin E tocotrienols inhibition of intracellularly obligate pathogen Chlamydia and methods of use
#2274Compositions and Methods for the Treatment of Diseases Related to the Renin-Angiotensin-System
#2275METHODS OF TREATING COLITIS
#2276COMPOSITIONS AND METHODS FOR OBTAINING AN IMPROVED LUNG FUNCTION
#22774'-Fluoro-2'-Methyl Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication
#2278INHIBITORY COMPOSITIONS
#2279Cholecalciferol sulfate salts and their use for the treatment of vitamin D deficiency
#2280TOPICAL TREATMENT REGIMENS CONTAINING A PROSTAGLANDIN F2a ANALOG AND A TOPICAL STEROID
#2281METHODS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
#2282Methods
#2283ANTIVIRAL THERAPY
#2284TREATMENT OF HEARING AND BALANCE IMPAIRMENTS WITH REDOX-ACTIVE THERAPEUTICS
#2285Methods of improving cell-based therapy
#2286Pharmaceutical compositions comprising an integrin ALPHA4 antagonist for use in treating ocular inflammatory conditions
#2287COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS
#2288IL-8 inihibitors for use in the treatment of some urological disorders
#2289Methods of targeting APE/Ref-1 to inhibit hypoxia signaling genes
#2290Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
#2291TRANSPAPILLARY METHODS AND COMPOSITIONS FOR TREATING BREAST DISORDERS
#2292MULTIPLE PILL ABUSE-RESISTANT IMMEDIATE RELEASE SOLID DOSAGE FORM OF HYDROCODONE
#2293Buffered microencapsulated compositions and methods
#2294CHEWABLE COMPOSITION COMPRISING A PHARMACEUTICALLY ACTIVE INGREDIENT
#2295Methods for treating neurological disorders using a synergistic small molecule and nucleic acids therapeutic approach
#2296PREVENTION OF METASTASIS AND RECURRENCE AFTER PRIMARY CANCER TREATMENT
#2297Peptides and compositions for treatment of joint damage
#2298Compositions and methods for preventing or treating diseases, conditions or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
#2299Substituted nucleosides, nucleotides and analogs thereof
#2300Hydantoins that modulate BACE-mediated APP processing
#2301COMPOUNDS FOR THE TREATMENT OF OBESITY AND METHODS OF USE THEREOF
#2302Drug formulation based on particulates comprising polysaccharide-vitamin conjugate
#2303Pharmaceutical compositions to reduce complications of ocular steroid
#2304PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#2305MUTATED FIBROBLAST GROWTH FACTOR (FGF) 1 AND METHODS OF USE
#2306COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDERS
#2307COMPOSITION FOR TREATMENT OF RSV
#2308Method of increasing omega-3 content in poultry
#2309Topical treatments incorporating . derived botanical drug product
#2310infused sweeteners and elixirs
#2311INDUCTION OF LAMINA PROPRIA REGULATORY T CELLS
#2312Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer
#2313NOVEL BIOMARKER FOR DIAGNOSING RESISTANCE TO ANTICANCER AGENT FOR BILLARY TRACT CANCER AND USE THEREOF
#2314Method for prolonging the over survival of a cancer patient
#2315Inhibition of HIV infection through chemoprophylaxis
#2316Methods and compositions for protection of cells and tissues from computed tomography radiation
#2317Tofacitinib oral sustained release dosage forms
#2318INHIBITORS OF BRUTON'S TYROSINE KINASE FOR THE TREATMENT OF SOLID TUMORS
#2319Systems and methods for treating an opioid-induced adverse pharmacodynamic response
#2320Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats
#2321Drug compositions
#2322Use of indole compounds for fat reduction and skin and soft tissue tightening
#2323Ultra low dose doxepin and methods of using the same to treat sleep disorders
#2324GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes
#2325PHARMACEUTICAL COMPOSITION COMPRISING AMLODIPINE AND DEXTROMETHORPHAN
#2326EXOSOMAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE
#2327Extracellular vesicles derived from osteoblastic lineage cells for therapeutic and diagnostic use
#2328Medicament for the treatment of viral skin and tumour diseases
#2329MULTIFUNCTIONAL IMMATURE DENTAL PULP STEM CELLS AND THERAPEUTIC APPLICATIONS
#2330Anti-CD276 antibodies (B7H3)
#2331Chimeric fibroblast growth factor 21 proteins and methods of use
#2332ANTIVIRAL COMPOUNDS
#2333SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AND ANALOGUES AS SIRTUIN MODULATORS
#2334Methods to treat lymphoplasmacytic lymphoma
#2335Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them
#23367,8-dihydoxyflavone and 7,8-substituted flavone derivatives, compositions, and methods related thereto
#2337ASSESSMENT OF CORONARY HEART DISEASE WITH CARBON DIOXIDE
#2338ST-246 liquid formulations and methods
#2339Cochleates made with soy phosphatidylserine
#2340Method to achieve extended expression of DNA infused into liver
#2341COMBINATION OF A PD-1 ANTAGONIST AND A LISTERIA-BASED VACCINE FOR TREATING PROSTATE CANCER
#2342Treatment for myopathy
#2343Composition containing palmultang extract for promoting proliferation of stem cells derived from bone marrow
#2344Use of potassium hydroxide in the treatment of actinic keratosis
#2345COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTION
#2346Pharmaceutical composition containing Celecoxib
#2347Preservative free bimatoprost and timolol solutions
#2348DRUG THERAPY FOR PREVENTING OR TREATING GLAUCOMA
#2349Meloxicam for the treatment of respiratory diseases in pigs
#2350INHIBITORS OF MTOR KINASE AS ANTI-VIRAL AGENTS
#2351METHODS AND COMPOSITIONS FOR TREATING THYROID-RELATED MEDICAL CONDITIONS WITH REDUCED FOLATES
#2352Systems and methods for treating cancer
#2353Pharmaceutical Combinations
#2354Methods for treating cancer using dihydropyrazino-pyrazine compound combination therapy
#2355Use of levocetirizine and montelukast in the treatment of traumatic injury
#2356Immediate release abuse-deterrent granulated dosage forms
#2357ABUSE-RESISTANT CONTROLLED-RELEASE OPIOID DOSAGE FORM
#2358Therapy of small-cell lung cancer (SCLC) with a topoisomerase-I inhibiting antibody-drug conjugate (ADC) targeting Trop-2
#2359Resiquimod topical and injectable compositions for the treatment of neoplastic skin conditions
#2360TETRAHYDROCYCLOPENTA[B]INDOLE COMPOUNDS AND PHOSPHODIESTERASE INHIBITORS FOR THE TREATMENT OF THE SIGNS AND SYMPTOMS OF BHP
#2361METHODS AND COMPOSITIONS FOR TREATING HERPESVIRUS INDUCED CONDITIONS
#2362Treatment of BRCA1-defective cancer or resistant cancers
#2363Therapeutic agent for dyslipidemia
#2364PARASITICIDAL ORAL VETERINARY COMPOSITIONS COMPRISING SYSTEMICALLY-ACTING ACTIVE AGENTS, METHODS AND USES THEREOF
#236512H-BENZO[b]XANTHEN-12-ONES, COMPOSITIONS CONTAINING, AND USES OF, SAME
#2366NOVEL CANNABINOID COMBINATION THERAPIES FOR MULTIPLE MYELOMA (MM)
#2367Talc-bound compositions and uses thereof
#2368PHARMACEUTICAL COMPOSITIONS CONTAINING DIMETHYL FUMARATE
#2369Combination methods and compositions including sleep therapeutics for treating mood
#2370Compounds for the treatment of obesity and methods of use thereof
#2371Modified release orally administered amino acid formulations
#2372PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY
#2373Cannabidiol for the prevention and treatment of graft-versus-host disease
#2374Pharmaceutical compositions
#2375Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant ovarian cancer
#2376Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof
#2377Antiviral methods and compositions comprising probiotic bacterial molecules
#2378Therapeutic combination comprising a pulmonary surfactant and a steroid for the treatment of evolving BPD
#2379Compositions for the Restoration of a Fecal Microbiota and Methods for Making and Using Them
#2380Compositions and methods for treating biofilms
#2381Compositions and methods for aerodigestive treatment
#2382Acetic acid and hypochlorous acid compositions for treatment of skin trauma
#2383TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA WITH IVERMECTIN
#2384Composition comprising HMSs/HMOs and use thereof
#2385Topical compositions and methods for treating psoriasis
#2386Pharmaceutical compositions and methods for anesthesiological applications
#2387Pharmaceutical compositions and methods for anesthesiological applications
#2388METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS USING AN SGLT-2 INHIBITOR AND A NEUROLEPTIC AGENT
#2389MONOAMINE OXIDASE INHIBITORS AND METHODS FOR TREATMENT AND DIAGNOSIS OF PROSTATE CANCER
#2390HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
#2391Use of anti-connexin agents for enhancing the therapeutic effect of acetylcholinesterase inhibitors
#2392COMBINATION MEDICATION FOR NEURO-DEGENERATIVE DISEASES
#2393ENGINEERED MODEL OF FIBROTIC DISEASES
#2394Inhibitors of CXCR2
#2395Resorcinol derivatives
#2396Antibody drug conjugates (ADCS) and antibody prodrug conjugates (APDCS) with enzymatically cleavable groups
#2397Treatment of ovarian cancer in patients with ascites using a specific binding agent of human angiopoietin-2 in combination with a taxane
#2398Combination of a PD-1 antagonist and CPG-C type oligonucleotide for treating cancer
#2399Combination vaccines with lower doses of antigen and/or adjuvant
#2400Combination of vaccination and inhibition of the PD-1 pathway